Chester County News and Community Website
WILMINGTON, DE — AstraZeneca has launched a national cancer awareness campaign aimed at increasing biomarker testing among U.S. patients, addressing a gap in cancer care as the pharmaceutical industry increasingly …
AstraZeneca Targets Cancer Testing Gap With New Campaign Read More
WILMINGTON, DE — Incyte Corp. (Nasdaq: INCY) is advancing two experimental cancer treatments into late-stage clinical development after early trials showed tumor responses in patients with pancreatic and colorectal cancers, …
Incyte Advances Pancreatic and Colorectal Cancer Drug Trials Read More
PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network has published its first patient guideline dedicated to cancer caregivers, expanding its clinical education resources to address the medical, financial and …
NCCN Expands Cancer Care Guidance to Family Caregivers Read More WILMINGTON, DE — AstraZeneca’s experimental cancer drug sonesitatug vedotin reduced the risk of death by 53% in patients receiving third-line or later treatment for advanced gastric and related cancers, according …
AstraZeneca Drug Cuts Death Risk in Advanced Gastric Cancer Read More WILMINGTON, DE — AstraZeneca’s TAGRISSO combined with savolitinib extended median survival by nearly five months compared with chemotherapy in a Phase III trial involving patients with EGFR-mutated non-small cell lung …
AstraZeneca Drug Combination Extends Lung Cancer Survival Read More WILMINGTON, DE — AstraZeneca’s IMFINZI combined with Amgen’s tarlatamab-dlle extended median survival to 21.1 months in patients with extensive-stage small cell lung cancer, compared with 12.7 months for IMFINZI alone, …
AstraZeneca Drug Combination Extends Lung Cancer Survival Read More WILMINGTON, DE — AstraZeneca has launched ZEGFROVY (sunvozertinib) in the United States for adults with a specific form of advanced lung cancer that has progressed following platinum-based chemotherapy, expanding access …
AstraZeneca Launches Targeted Lung Cancer Drug in U.S. Read More
PHILADELPHIA, PA — The U.S. Food and Drug Administration has granted accelerated approval to GSK’s Jemperli as a standalone treatment for certain patients with locally advanced rectal cancer, creating an …
FDA Approves GSK’s Jemperli for Certain Rectal Cancer Patients Read More
MALVERN, PA — Unite for HER is expanding a national breast cancer support program with TOUCH, The Black Breast Cancer Alliance, to provide free patient services aimed at reducing treatment-related …
Unite for HER Expands Breast Cancer Support for Black Women Read More
PLYMOUTH MEETING, PA — More than 81% of families with children undergoing treatment for B-cell acute lymphoblastic leukemia experienced employment or marital changes within 26 months of diagnosis, according to …
Childhood Leukemia Treatment Disrupts 81% of Families, Study Finds Read More